Capricorn Fund Managers Ltd Decreases Stake in Astera Labs, Inc. $ALAB

Capricorn Fund Managers Ltd cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 88.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,689 shares of the company’s stock after selling 44,311 shares during the quarter. Capricorn Fund Managers Ltd’s holdings in Astera Labs were worth $624,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ALAB. Vanguard Group Inc. boosted its holdings in shares of Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after purchasing an additional 84,365 shares during the last quarter. State Street Corp grew its position in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Fred Alger Management LLC increased its holdings in shares of Astera Labs by 25.5% in the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares during the last quarter. Finally, Morgan Stanley increased its holdings in shares of Astera Labs by 33.0% in the fourth quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock valued at $321,818,000 after purchasing an additional 480,009 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other news, Director Bethany Mayer sold 686 shares of the company’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the transaction, the director owned 5,550 shares of the company’s stock, valued at $2,192,472. This represents a 11.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,968,942 shares of company stock valued at $439,344,964. 10.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of recent research reports. Needham & Company LLC boosted their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. upped their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Susquehanna raised their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Bank of America boosted their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $265.75.

Astera Labs Stock Performance

ALAB stock opened at $483.02 on Wednesday. The firm has a market cap of $82.79 billion, a PE ratio of 326.36, a PEG ratio of 5.23 and a beta of 3.95. The firm’s 50 day moving average price is $301.08 and its 200-day moving average price is $200.51. Astera Labs, Inc. has a one year low of $85.85 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.